CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus

2024 . Ferrero, Fernando | Lin, Chien-Yu | Liese, Johannes | Luz, Kleber | Stoeva, Tatyana | Nemeth, Agnes | Gijón, Manuel | Calvo, Cristina | Natalini Martinez, Silvina | Toh, Teck-Hock | Deleu, Sofie | Chen, Bohang | Rusch, Sarah | Sánchez, Beatriz López | Leipoldt, Illse | Vijgen, Leen | Huntjens, Dymphy | Baguet, Tristan | Bertzos, Kristi | Gamil, Mohamed | Stevens, Marita | the CROCuS Investigators